Change of Auditor
3 December 2019
CEIBA INVESTMENTS LIMITED
(TICKER CBA, ISIN: GG00BFMDJH11)
Legal Entity Identifier: 213800XGY151JV5B1E88
CHANGE OF AUDITOR
CEIBA Investments Limited, the largest listed foreign investor solely dedicated to investing in Cuba, announces that the Board has appointed Grant Thornton Limited as Auditor of the Company with immediate effect. This appointment follows a formal and competitive tender process.
Ernst & Young LLP Guernsey has resigned from the position and has confirmed that there are no matters that it wishes to bring to the attention of the Board of Directors or the Shareholders of the Company.
The Board would like to thank Ernst & Young for its professional service to the Company throughout its tenure in office.
Shareholder approval to re-appoint Grant Thornton Limited as the Company's auditor will be sought at the Company's next Annual General Meeting to be held in the summer of 2020.
The Company also announces that Peter Cornell has stepped down from the Company's audit committee, as Peter is a non-executive director of Grant Thornton Limited and is therefore not considered independent for the purposes of the audit committee. The audit committee now comprises of Trevor Bowen (Chairman of the audit committee) and Keith Corbin. The Company also confirms that Peter had no involvement in the appointment of Grant Thornton Limited as auditor and that he stepped aside from the audit tender process described above.
For further information, please contact:
Aberdeen Standard Fund Managers Limited
Sebastiaan Berger / Evan Bruce-Gardyne / Christian Pittard
Tel: +44 (0)20 7463 6000
James Maxwell / James Moat (Corporate Finance)
James Waterlow (Sales)
Tel: +44 (0)20 7496 3000
JTC Fund Solutions (Guernsey) Limited
Tel: +44 (0) 1481 702400
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.